Effects of jujube fruits on lipid profile in hyperlipidemic patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201308319662N7

Enrollment

Registered

2013-09-23

Start date

2013-11-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Other disorders of lipoprotein metabolism. Condition 2: Pure hypercholesterolaemia. Condition 3: Hyperlipidaemia, unspecified. Other disorders of lipoprotein metabolism Pure hypercholesterolaemia Hyperlipidaemia, unspecified

Interventions

Intervention 1: control group: take placebo capsol twice a day after the lunch and dinner for a month. Intervention 2: case group: take Ziziphus vulgaris capsol twice a day after the lunch and dinne

Placebo

Treatment - Drugs

control group: take placebo capsol twice a day after the lunch and dinner for a month

case group: take Ziziphus vulgaris capsol twice a day after the lunch and dinne for a monthr

case group: taking one Atorvastatin Tableta day after the lunch and dinner

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : in hyperlipidemic patients; subjects aged 35–70 years ; over 5/18 mM cholesterol (200 mg per deciliter); over 3/ 37mM LDL (130 mg dL). exclusion criteria : Individuals with a history of diseases; diabetes; cardiovascular disease; liver and kidney as well as pregnant and breastfeeding; supplements like fish oil which is affect on blood lipids levels; the use of immunosuppressive drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total cholestrol. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;HDL. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;LDL. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;TG. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.	—

Secondary

Measure	Time frame
Hs-CRP. Timepoint: Before and after 4 weeks. Method of measurement: ELISA Kit.;Apo A. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;Apo 8. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.;FBS. Timepoint: Before and after 4 weeks. Method of measurement: Parss Azmon KIT/Device Hitachi.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026